Carregando empresa
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 3 de novembro de 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 205,9M
-3,6% y/y
-7,8% q/qGuided
—
No guide given
EPS, GAAP
Actual
-US$ 0,30
Guided
—
No guide given
Operating income, GAAP
Actual
-US$ 1,4M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker CoUS$ 14,2BA
MKCMccormick & Company, IncorporatedUS$ 12,7BA+
FRPTFreshpet, Inc.US$ 3,3BA
DARDarling Ingredients Inc.US$ 8,7BB+
POSTPost Holdings, Inc.US$ 3,6BB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30 de jul. de 2026BAGraded B, now A
MDLZMondelez International, Inc.29 de out. de 2026CAGraded C, now A
HSYHershey Co.29 de out. de 2026BAGraded B, now A
SYYSysco Corporation4 de nov. de 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.4 de nov. de 2026BAGraded B, now A
Demonstrações financeiras completas →
Construído a partir dos próprios documentos de Usana Health Sciences, Inc. entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.
